Literature DB >> 15012564

Asthma prevalence in Melbourne schoolchildren: have we reached the peak?

Colin F Robertson1, Mary F Roberts, Johanna H Kappers.   

Abstract

OBJECTIVE: To determine the change in prevalence of asthma, eczema and allergic rhinitis in Australian schoolchildren between 1993 and 2002.
DESIGN: Questionnaire based survey, using the protocol of the International Study of Asthma and Allergy in Childhood.
SETTING: Metropolitan Melbourne primary schools within a 20 km radius of the GPO in 1993 and 2002.
SUBJECTS: All children in school years 1 and 2 (ages 6 and 7) attending a random sample of 84 schools in 1993 and 63 schools in 2002. MAIN OUTCOME MEASURES: Parent-reported symptoms of atopic disease; treatment for asthma; country of birth.
RESULTS: There was a 26% reduction in the 12-month period prevalence of reported wheeze, from 27.2% in 1993 to 20.0% in 2002. The magnitude of reduction was similar for boys (27%) and girls (25%). The 12-month period prevalence of reported eczema increased from 11.1% in 1993 to 17.2% in 2002, and rhinitis increased from 9.7% to 12.7%. There were reductions in the proportion of children attending an emergency department for asthma in the previous year (3.6% to 2.3%), the proportion admitted to hospital (1.7% to 1.1%) and the proportion taking asthma medication (18.5% to 13.4%). Of those who reported frequent wheeze, there was an increase in the proportion taking regular inhaled steroids (34.5% to 40.9%).
CONCLUSION: There has been a significant reduction in the prevalence of reported asthma in Melbourne schoolchildren, whereas the prevalence of eczema and allergic rhinitis has continued to increase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15012564

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  31 in total

Review 1.  Air Pollution and Allergic Airway Diseases: Social Determinantsand Sustainability in the Control and Prevention.

Authors:  H Paramesh
Journal:  Indian J Pediatr       Date:  2018-01-09       Impact factor: 1.967

2.  Prevalence of asthma.

Authors:  H Ross Anderson
Journal:  BMJ       Date:  2005-05-07

Review 3.  Exposure to cats: update on risks for sensitization and allergic diseases.

Authors:  Shyamali C Dharmage; Caroline L Lodge; Melanie C Matheson; Brittany Campbell; Adrian J Lowe
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

4.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

Review 5.  Importance of allergy in asthma: an epidemiologic perspective.

Authors:  Jeroen Douwes; Collin Brooks; Christine van Dalen; Neil Pearce
Journal:  Curr Allergy Asthma Rep       Date:  2011-10       Impact factor: 4.806

6.  Short-term roxithromycin treatment attenuates airway inflammation via MAPK/NF-κB activation in a mouse model of allergic asthma.

Authors:  Xinxin Ci; Xiao Chu; Xue Xu; Hongyu Li; Xuming Deng
Journal:  Inflamm Res       Date:  2012-04-06       Impact factor: 4.575

7.  Maternal smoking in pregnancy: do the effects on innate (toll-like receptor) function have implications for subsequent allergic disease?

Authors:  Susan L Prescott; Paul S Noakes
Journal:  Allergy Asthma Clin Immunol       Date:  2007-03-15       Impact factor: 3.406

8.  Prevalence of asthma in school children in rural India.

Authors:  Pradeepa P Narayana; Mithra P Prasanna; S R Narahari; Aggithaya M Guruprasad
Journal:  Ann Thorac Med       Date:  2010-04       Impact factor: 2.219

9.  Oral immunotherapy for food allergy.

Authors:  Mimi L K Tang
Journal:  Curr Allergy Asthma Rep       Date:  2009-01       Impact factor: 4.806

10.  Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC).

Authors:  Neil Pearce; Nadia Aït-Khaled; Richard Beasley; Javier Mallol; Ulrich Keil; Ed Mitchell; Colin Robertson
Journal:  Thorax       Date:  2007-05-15       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.